Title of Collaborative Activity:
Best Pharmaceuticals for Children Act Activities
Description of Collaborative Activity:
NIH, FDA, and non-Federal experts in pediatric pharmacology meet several times a year to identify important unmet needs for conducting research on the efficacy and safety of medications in children.
Type of Collaborative Activity:
Advisory Group
Year the Collaborative Activity Originated:
Unknown
NIH Participating Institutes/Centers/Office of the Director:
NHLBI, NICHD, NIMH
HHS Agency Collaborators on this Activity:
FDA